Therefore, specific TNFR2 agonism would have two desired cellular immune effects for treatment of autoimmune diseases: (1) selective death of autoreactive T cells and (2) expansion of beneficial Treg. The gene discussed is TNFRSF1B; the disease is autoimmune disease.